Enzo Biochem (ENZ) Competitors $0.52 -0.01 (-2.33%) As of 02/21/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ENZ vs. EUDA, XGN, TOI, PIII, BNR, CCM, BRTX, MRAI, MGRX, and OPGNShould you be buying Enzo Biochem stock or one of its competitors? The main competitors of Enzo Biochem include EUDA Health (EUDA), Exagen (XGN), Oncology Institute (TOI), P3 Health Partners (PIII), Burning Rock Biotech (BNR), Concord Medical Services (CCM), BioRestorative Therapies (BRTX), Marpai (MRAI), Mangoceuticals (MGRX), and OpGen (OPGN). These companies are all part of the "healthcare" industry. Enzo Biochem vs. EUDA Health Exagen Oncology Institute P3 Health Partners Burning Rock Biotech Concord Medical Services BioRestorative Therapies Marpai Mangoceuticals OpGen EUDA Health (NASDAQ:EUDA) and Enzo Biochem (NYSE:ENZ) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, community ranking, media sentiment, earnings, dividends and risk. Do insiders and institutionals have more ownership in EUDA or ENZ? 4.4% of EUDA Health shares are owned by institutional investors. Comparatively, 36.9% of Enzo Biochem shares are owned by institutional investors. 11.4% of Enzo Biochem shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has more risk & volatility, EUDA or ENZ? EUDA Health has a beta of -0.04, meaning that its stock price is 104% less volatile than the S&P 500. Comparatively, Enzo Biochem has a beta of 0.81, meaning that its stock price is 19% less volatile than the S&P 500. Which has higher valuation & earnings, EUDA or ENZ? EUDA Health has higher earnings, but lower revenue than Enzo Biochem. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEUDA Health$3.71M26.49-$10.04MN/AN/AEnzo Biochem$31.91M0.84-$26.08MN/AN/A Is EUDA or ENZ more profitable? EUDA Health has a net margin of 0.00% compared to Enzo Biochem's net margin of -75.34%. EUDA Health's return on equity of 0.00% beat Enzo Biochem's return on equity.Company Net Margins Return on Equity Return on Assets EUDA HealthN/A N/A N/A Enzo Biochem -75.34%-7.96%-5.49% Does the MarketBeat Community prefer EUDA or ENZ? Enzo Biochem received 211 more outperform votes than EUDA Health when rated by MarketBeat users. However, 100.00% of users gave EUDA Health an outperform vote while only 53.67% of users gave Enzo Biochem an outperform vote. CompanyUnderperformOutperformEUDA HealthOutperform Votes1100.00% Underperform VotesNo VotesEnzo BiochemOutperform Votes21253.67% Underperform Votes18346.33% Does the media prefer EUDA or ENZ? In the previous week, EUDA Health had 2 more articles in the media than Enzo Biochem. MarketBeat recorded 3 mentions for EUDA Health and 1 mentions for Enzo Biochem. Enzo Biochem's average media sentiment score of 0.46 beat EUDA Health's score of 0.26 indicating that Enzo Biochem is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment EUDA Health 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Enzo Biochem 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts recommend EUDA or ENZ? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score EUDA Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00Enzo Biochem 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryEUDA Health beats Enzo Biochem on 9 of the 15 factors compared between the two stocks. Get Enzo Biochem News Delivered to You Automatically Sign up to receive the latest news and ratings for ENZ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ENZ vs. The Competition Export to ExcelMetricEnzo BiochemMedical laboratories IndustryMedical SectorNYSE ExchangeMarket Cap$26.96M$3.11B$5.77B$20.07BDividend Yield77.21%20.51%4.78%3.65%P/E RatioN/A15.6226.4634.90Price / Sales0.84209.90455.0215.64Price / CashN/A387.2444.0420.85Price / Book0.474.847.634.92Net Income-$26.08M-$22.21M$3.18B$1.02B7 Day Performance-4.44%-4.33%-1.91%-1.05%1 Month Performance-21.82%-2.39%-0.19%-1.09%1 Year Performance-62.61%13.74%16.70%13.70% Enzo Biochem Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ENZEnzo Biochem1.5046 of 5 stars$0.52-2.1%N/A-61.2%$26.96M$31.91M0.00520Analyst ForecastNews CoverageEUDAEUDA Health0.405 of 5 stars$4.00-8.5%N/A+175.2%$98.52M$3.71M0.002XGNExagen4.3241 of 5 stars$4.80-7.0%$7.50+56.3%+77.2%$84.67M$52.55M-5.11220TOIOncology Institute2.5577 of 5 stars$1.00+22.0%$2.50+150.0%-51.6%$75.56M$324.24M-1.28660News CoveragePIIIP3 Health Partners3.3423 of 5 stars$0.20-0.5%$2.38+1,117.3%-80.2%$70.01M$1.27B-0.23500Positive NewsBNRBurning Rock Biotech0.6348 of 5 stars$6.25-3.5%N/A-17.7%$64M$75.70M-2.081,390Gap UpCCMConcord Medical Services0.6213 of 5 stars$5.06-1.9%N/A-36.2%$21.97M$471.70M0.00970Analyst ForecastNews CoverageGap DownBRTXBioRestorative Therapies3.1543 of 5 stars$2.44+6.1%$18.00+637.7%+32.0%$16.89M$150,000.00-1.597News CoverageMRAIMarpaiN/A$1.00+8.7%$6.00+500.0%-33.0%$14.48M$37.15M-0.38150MGRXMangoceuticals0.8031 of 5 stars$4.21-0.9%N/A-91.2%$10.48M$730,000.00-0.733News CoverageHigh Trading VolumeOPGNOpGenN/A$1.20-8.4%N/A-70.2%$10.03M$2.67M0.00100Analyst Forecast Related Companies and Tools Related Companies EUDA Health Competitors Exagen Competitors Oncology Institute Competitors P3 Health Partners Competitors Burning Rock Biotech Competitors Concord Medical Services Competitors BioRestorative Therapies Competitors Marpai Competitors Mangoceuticals Competitors OpGen Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:ENZ) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enzo Biochem, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enzo Biochem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
